Etoricoxib 90 mg + Cyclobenzaprine 5 mg Tablet – Manufacturer, Supplier & PCD Franchise



Etoricoxib 90 mg + Cyclobenzaprine 5 mg Tablet — available for PCD franchise from Trumac Healthcare

Etoricoxib 90 mg + Cyclobenzaprine 5 mg Tablet

Etoricoxib 90 mg + Cyclobenzaprine 5 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing

Composition: Etoricoxib 90 mg + Cyclobenzaprine 5 mg
Form: Tablet
Class: Selective COX-2 Inhibitor — NSAID
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ Available Now

Pricing, brochure & monopoly territory within 24 hrs.

Etoricoxib 90 mg + Cyclobenzaprine 5 mg Tablet is available from Trumac Healthcare, a PCD pharma franchise company and supplier in India whose products are made at WHO-GMP certified partner units. This tablet formulation is offered on monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing basis across all Indian states. We already supply Etoricoxib, Cyclobenzaprine across our existing range, so supply is established and lead times are short.

Therapeutic Indications
  • Conditions for which a cox-2 inhibitor is clinically indicated
  • Prescribed as monotherapy or in combination per treating physician
  • Use strictly on the advice of a registered medical practitioner
Mechanism of Action

The cox-2 inhibitor component selectively inhibits cyclo-oxygenase-2, reducing inflammatory prostaglandins with less GI injury. Where the formulation is a fixed-dose combination, the components act complementarily on the target condition. Refer to the approved prescribing information for full pharmacology.

Dosage & Administration
  • Dosage of Etoricoxib 90 mg + Cyclobenzaprine 5 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
  • Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
  • Do not exceed the prescribed dose, and complete the full course as advised.
  • Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
  • To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
  • Class-related adverse effects associated with cox-2 inhibitor therapy
  • Gastrointestinal intolerance in some patients
  • Hypersensitivity reactions (uncommon)
  • Refer to prescribing information for the complete adverse-event profile
Contraindications
  • Known hypersensitivity to any component of the formulation
  • Contraindications applicable to the cox-2 inhibitor class
  • Use with caution in renal or hepatic impairment
  • Pregnancy and lactation — only if clearly indicated, under medical supervision
Storage

Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.

Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the orthopaedic pharma franchise product list (PDF). See our full tablet range for PCD franchise. Comparing companies? See the top ortho PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.


ETOCAM-PLUS Tablet – Etoricoxib 90mg + Cyclobenzaprine HCL 5mg – Trumac Healthcare PCD franchise

Our own brand: ETOCAM-PLUS Tablet – Etoricoxib 90mg + Cyclobenzaprine HCL 5mg. Pack: 10 x 10 (Alu-Alu).

Supplied by Trumac Healthcare for PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. Made at WHO-GMP certified partner units; no franchise fee, first order from ₹25,000.

WhatsApp +91 90416 77932 for net rate

For chemists, distributors and doctors: need Etoricoxib 90 mg + Cyclobenzaprine 5 mg Tablet for a PCD franchise or wholesale? Trumac Healthcare checks availability with its WHO-GMP certified partner units and quotes on enquiry – no franchise fee; first order from ₹25,000.

WhatsApp your requirement

See the full pain relief & muscle relaxant range – manufacturer, supplier and PCD franchise: aceclofenac, diclofenac, etoricoxib, lornoxicam, paracetamol, serratiopeptidase, thiocolchicoside and tizanidine.

PCD Pharma Franchise & Third Party Manufacturing — Etoricoxib + Cyclobenzaprine Tablet

  • ✓ Made at WHO-GMP certified partner units — every batch QC released
  • ✓ Monopoly PCD franchise rights at district or state level
  • ✓ Third party / contract manufacturing under your own brand
  • ✓ Wholesale and distributor supply against drug licence + GST
  • ✓ Attractive net rates with healthy PTR / PTS margins
  • ✓ Dispatch within 48 hours of payment realisation

Composition: Etoricoxib 90 mg + Cyclobenzaprine 5 mg. Trumac Healthcare supplies this cox-2 inhibitor with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.

PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Etoricoxib + Cyclobenzaprine Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.

Frequently Asked Questions

Who manufactures Etoricoxib + Cyclobenzaprine Tablet in India?

Trumac Healthcare is a supplier of Etoricoxib + Cyclobenzaprine Tablet in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.

Is Etoricoxib + Cyclobenzaprine Tablet available for PCD pharma franchise on monopoly basis?

Yes. Etoricoxib 90 mg + Cyclobenzaprine 5 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.

Do you offer Etoricoxib + Cyclobenzaprine for third party or contract manufacturing?

Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Etoricoxib + Cyclobenzaprine Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.

Can Etoricoxib + Cyclobenzaprine Tablet be supplied on wholesale or distributor basis?

Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.

What is the therapeutic class of Etoricoxib + Cyclobenzaprine?

Etoricoxib + Cyclobenzaprine is classified as a COX-2 Inhibitor — Selective COX-2 Inhibitor — NSAID.

What documentation is provided with each supply?

Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.

How quickly can an order be dispatched?

Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.

Is a prescription required for Etoricoxib + Cyclobenzaprine Tablet?

Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.

Ready to start your PCD franchise for Etoricoxib 90 mg + Cyclobenzaprine 5 mg Tablet?

Get Pricing & Franchise Terms →